Recent Posts by Feldan:
on Jun 18,2025
BOSTON, June 16, 2025 – CQDM is proud to announce the funding of two collaborative research projects focused on the development of RNA-based therapies. Unveiled during the BIO International Convention …
Read Storyon Apr 16,2025
Pennington, NJ, USA & Québec, Canada – April 16, 2025 – Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in …
Read Storyon Feb 18,2025
Quebec City, Canada – February 18, 2025 – Feldan Therapeutics ("Feldan"), a clinical-stage pharmaceutical company specialized in the development of treatments based on intracellular delivery of therapeutics, is pleased to …
Read Storyon Jan 22,2025
Quebec City, Canada, January 22, 2025 — Feldan Therapeutics (“Feldan”), a clinical-stage pharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, is pleased to announce …
Read Storyon Oct 31,2024
Quebec City, Canada & Sydney, Australia, October 31 2024 - Feldan Therapeutics (Feldan), a biopharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, has announced …
Read Storyon Sep 4,2024
Quebec City and Toronto, Canada, September 4th, 2024 – Feldan Therapeutics (Feldan), a biopharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, has announced the …
Read Storyon Feb 23,2024
It was with great pride and emotion that our team had the privilege of donating $11,197 to the Make-A-Wish | Children's Wish Canada Foundation. This fundraiser was made possible by …
Read Storyon Sep 1,2023
Congratulations to Xiaoming Liu’s team for the publication of the article: Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/nucleases Delivered with Amphiphilic Shuttle Peptides The team used our delivery …
Read Storyon Jun 13,2023
Québec City, Canada, June 13, 2023 – Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, has announced the initial closing …
Read Storyon Jun 16,2020
Quebec City, Canada, June 16, 2020, Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on its intracellular delivery technology, today announced the appointment of Dr. Robert …
Read Story